Terms: = Sarcomas AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG AND Treatment
3 results:
1. Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.
Yuan B; Shi K; Zha J; Cai Y; Gu Y; Huang K; Yue W; Zhai Q; Ding N; Ren W; He W; Xu Y; Wang T
Cell Death Dis; 2023 Jan; 14(1):51. PubMed ID: 36681687
[TBL] [Abstract] [Full Text] [Related]
2. Network pharmacology, molecular docking and bioinformatics reveal the mechanism of Tripterygii Wilfordii against Osteosarcoma.
Zhang Y; Wei J; Kong L; Song M; Zhang Y; Xiao X; Cao H; Jin Y
Medicine (Baltimore); 2022 Dec; 101(52):e32389. PubMed ID: 36595977
[TBL] [Abstract] [Full Text] [Related]
3. Exploring the association mechanism between metastatic osteosarcoma and non-metastatic osteosarcoma based on dysfunctionality module.
Xiong J; Li T
J BUON; 2020; 25(3):1569-1578. PubMed ID: 32862606
[TBL] [Abstract] [Full Text] [Related]
